Advances in Molecular Biology

Research Article

Beta2-Adrenergic Receptor Gene Polymorphisms in Egyptian Patients with Acute Myocardial Infarction

Table 1

Baseline characteristics of the study groups.
VariablesPatients
()		Controls
()		 value*
Risk factors for CVD   
 Age, y53.5 ± 7.452.8 ± 6.10.203
 Male gender, %45 (66.2)53 (70.7)0.252
 Smokers, % 37 (54.4)15 (20.0)<0.001
 FH of CVD, %35 (51.5)17 (22.7)<0.001
 BMI, kg/m229.5 ± 3.627.4 ± 2.7<0.001
 Hypertension, %48 (70.6)— 
 SBP, mmHg129.7 ± 22.7122.0 ± 11.20.010
 DBP, mmHg83.8 ± 13.377.5 ± 7.70.001
 Diabetic, %32 (47.1)— 
 FBS, mg/dL129.2 ± 45.798.2 ± 11.3<0.001
Lipid profile   
 Hyperlipidemia, % 62 (91.2)38 (50.6)<0.001
 TC, mg/dL199 ± 40174 ± 400.002
 TG, mg/dL203 ± 63151 ± 84<0.001
 HDL-C, mg/dL38 ± 7.447.4 ± 12<0.001
 LDL-C, mg/dL121 ± 4196 ± 400.001
 VLDL-C, mg/dL40.5 ± 1330.2 ± 17<0.001
Cardiac enzymes   
 CK, ng/mL1688 ± 1832— 
 CK-MB. ng/mL320 ± 370— 
 LDH, IU/L1562 ± 1223— 
Values are presented as number (percentage) or mean ± standard deviation. Chi-square () and Mann-Whitney tests were used. *Statistically significant at < 0.05; FH: family history; CVS: cardiovascular disease; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBS: fasting blood sugar; TC: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; VLDL-C: very low density lipoprotein cholesterol; CK: total creatine kinase; CK-MB: creatine kinase isoenzyme MB fraction; LDH: lactate dehydrogenase.